Therapeutic efficacy of epigallocatechin gallate-loaded nanoliposomes against burn wound infection by methicillin-resistant staphylococcus aureus

Skin Pharmacology and Physiology

Volumn 26, Issue 2, 2013, Pages 68-75

  Gharib, A ^a   Faezizadeh, Z ^a   Godarzee, M ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Epigallocatechin gallate; Killing rate; Methicillin resistant Staphylococcus aureus; Nanoliposome; Surface charge

Indexed keywords

EPIGALLOCATECHIN GALLATE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BROTH DILUTION; BURN INFECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE CHARGE; SURVIVAL RATE; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; DRUG RELEASE; NANOENCAPSULATION; PARTICLE SIZE; PHARMACOLOGICAL PARAMETERS; POLYDISPERSITY INDEX; ZETA POTENTIAL;

ANIMALS; ANTI-BACTERIAL AGENTS; BURNS; CATECHIN; KIDNEY; LIPOSOMES; LIVER; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; NANOSTRUCTURES; SKIN; SPLEEN; STAPHYLOCOCCAL INFECTIONS; WOUND INFECTION;

EID: 84871884865     PISSN: 16605527     EISSN: 16605535     Source Type: Journal    
DOI: 10.1159/000345761     Document Type: Article

References (41)

1. Dai T, Huang YY, Sharma SK, Hashmi JT, Kurup DB, Hamblin MR: Topical antimicrobials for burn wound infections. Recent Pat Antiinfect Drug Discov 2010; 5: 124-151.
2. Schaller M, Laude J, Bodewaldt H, Hamm G, Korting HC: Toxicity and antimicrobial activity of a hydrocolloid dressing containing silver particles in an ex vivo model of cutaneous infection. Skin Pharmacol Physiol 2004; 17: 31-36.
3. Durupt F, Mayor L, Bes M, Reverdy ME, Vandenesch F, Thomas L, Etienne J: Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Br J Dermatol 2007; 157: 1161-1167.
4. Jeon HY, Kim JK, Kim WG, Lee SJ: Effects of oral epigallocatechin gallate supplementation on the minimal erythema dose and UV-induced skin damage. Skin Pharmacol Physiol 2009; 22: 137-141.
5. Grove KA, Lambert JD: Laboratory, epidemiological, and human intervention studies show that tea (Camellia sinensis) may be useful in the prevention of obesity. J Nutr 2010; 140: 446-453.
6. Zhao WH, Hu ZQ, Hara Y, Shimamura T: Inhibition of penicillinase by epigallocatechin gallate resulting in restoration of antibacterial activity of penicillin against penicillinase-producing Staphylococcus aureus . Antimicrob Agents Chemother 2002; 46: 2266-2268.
7. Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T: Mechanism of synergy between epigallocatechin gallate and-lactams against methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 2001; 45: 1737-1742.
8. Gaffari MA, Dabbagh MA, Gharib A: Human erythrocyte superoxide dismutase encapsulated in positively charged liposomes. Iranian J Pharm Sci 2005; 1: 153-160.
9. Mirzaee M, Owlia P, Mehrabi MR, Gharib A: In vitro bactericidal activity of encapsulated amikacin in liposome. Iranian J Pathol 2009; 4: 151-156.
10. Sarbolouki MN, Maghdooni Bagheri P, Saneei V: The influence of lipid composition and beta-carotene on lipid peroxidation in liposomes. Daru J Pharm Sci 2005; 13: 148-154.
11. Gharib A, Faezizadeh Z, Mohammad Asghari H: Preparation and antifungal activity of spray-dried amphotericin B-loaded nanospheres. Daru J Pham Sci 2011; 19: 351-355.
12. Zhong Z, Wan Y, Han J, Shi S, Zhang Z, Sun X: Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes. Int J Nanomedicine 2011; 6: 1083-1093.
13. Roychoudhury J, Sinha R, Ali N: Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice. PLoS One 2011; 6:e17376.
14. Fang JY, Hwang TL, Huang YL, Fang CL: Enhancement of the transdermal delivery of catechins by liposomes incorporating anionic surfactants and ethanol. Int J Pharm 2006; 310: 131-138.
15. Youfang J, Fenghung C, Longhwang T, Linghuang Y: Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations. J Drug Targ 2005; 13: 19-27.
16. Zhang L, Lu CT, Li WF, Cheng JG, Tian XQ, Zhao YZ, Li X, Lv HF, Li XK: Physical characterization and cellular uptake of propylene glycol liposomes in vitro. Drug Dev Ind Pharm 2012; 38: 365-371.
17. Kong KW, Khoo HE, K. Prasad N, Ismail A, Tan CP, Nor Fadilah Rajab NF: Revealing the power of the natural red pigment lycopene. Molecules 2010; 15: 959-987.
18. Fang JY, Lee WR, Shen SC, Huang YL: Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas. J Dermatol Sci 2006; 42: 101-109.
19. Pallotta RC, Ribeiro MS, de Lima Machado ME: Determination of the minimum inhibitory concentration of four medicaments used as intracanal medication. Aust Endod J 2007; 33: 107-111.
20. Wayne PA, National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard, ed 6. National Committee for Clinical Laboratory Standards, 2003, NCCLS document M7-A6.
21. Shrivastava SM, Saurabh S, Rai D, Dwivedi VK, Chaudhary M: In vitro microbial efficacy of Sulbactomax: a novel fixed dose combination of ceftriaxone sulbactam and ceftriaxone alone. Cur Drug Ther 2009; 4: 73-77.
22. Dale RK, Schnell G, Wong JP: Therapeutic efficacy of 'nubiotics' against burn wound infection by Pseudomonas aeruginosa. Antimicrob Agents Chemother 2004; 48: 2918-2923.
23. Committee on the Care and Use of Laboratory Animals of the Laboratory Animal Resources, Commission on Life Sciences National Research Council: Guide for the Care and Use of Laboratory Animals. Washington, National Academy Press, 1996.
24. Shaffa MW, Dayem SA, Elshemy WM: In vitro antibacterial activity of liposomal cephalexin against Staphylococcus aureus . Romanian J Biophys 2008; 18: 293-300.
25. Muqbil I, Masood A, Sarkar FH, Mohammad RM, Azmi AS: Progress in nanotechnologybased approaches to enhance the potential of chemopreventive agents. Cancers 2011; 3: 428-445.
26. Nagle DG, Ferreira D, Zhou YD: Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 2006; 67: 1849-1855.
27. Detoni CB, Cabral-Albuquerque EC, Hohlemweger SV, Sampaio C, Barros TF, Velozo EF: Essential oil from Zanthoxylum tingoassuiba loaded into multilamellar liposomes useful as antimicrobial agents. J Microencapsul 2009; 26: 684-691.
28. Odonkor ST, Addo KK: Bacteria resistance to antibiotics: recent trends and challenges. Int J Biol Med Res 2011; 2: 1204-1210.
29. Wright GD: Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev 2005; 57: 1451-1470.
30. Alanis AJ: Resistance to antibiotics: are we in the post-antibiotic era? Arch Med Res 2005; 36: 697-705.
31. Abreu AC, McBain AJ, Simões M: Plants as sources of new antimicrobials and resistance-modifying agents. Nat Prod Rep 2012; 29: 1007-1021.
32. Gibbons S: Plants as a source of bacterial resistance modulators and anti-infective agents. Phytochem Rev 2005; 4: 63-78.
33. Campanhã MT, Mamizuka EM, Carmona-Ribeiro AM: Interactions between cationic liposomes and bacteria: the physical chemistry of the bactericidal action. J Lipid Res 1999; 40: 1495-1500.
34. Mugabe C, Halwani M, Azghani AO, Lafrenie RM, Omri A: Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa . Antimicrob Agents Chemother 2006; 50: 2016-2022.
35. Drulis-Kawa Z, Dorotkiewicz-Jach A, Gubernator J, Gula G, Bocer T, Doroszkiewicz W: The interaction between Pseudomonas aeruginosa cells and cationic PC:Chol: DOTAP liposomal vesicles versus outermembrane structure and envelope properties of bacterial cell. Int J Pharm 2009; 367: 211-219.
36. Huang CM, Chen CH, Pornpattananangkul D, Zhang L, Chan M, Hsieh MF, Zhang L: Eradication of drug resistant Staphylococcus aureus by liposomal oleic acids. Biomaterials 2011; 32: 214-221.
37. Klein DG, Fritsh DE, Amin SG: Wound infection following trauma and burn injuries. Crit Care Nursing N Am 1995; 7: 627-642.
38. Pruitt BA, McManus AT, Kim SH, Goodwin CW: Burn wound infections: current status. World J Surg 1998; 22: 135-145.
39. Wurtz R, Karajovic E, Dacumos E, Hanumandass M: Nosocomial infections in a burn intensive care unit. Burns 1995; 21: 180-184.
40. Nunes PS, Albuquerque RL Jr, Cavalcante DR, Dantas MD, Cardoso JC, Bezerra MS, Souza JC, Serafini MR, Quitans LJ Jr, Bonjardim LR, Araújo AA: Collagen-based films containing liposome-loaded usnic acid as dressing for dermal burn healing. J Biomed Biotechnol 2011; 2011: 761593.
41. Karodi R, Jadhav M, Rub R, Bafna A: Evaluation of the wound healing activity of a crude extract of Rubia cordifolia L. (Indian madder) in mice. Int J Appl Res Nat Prod 2009; 2: 12-18.